Celyad Oncology Market Cap

Celyad Oncology has a market cap or net worth of €16.34 million as of March 6, 2026. Its market cap has decreased by -25.87% in one year.

Market Cap

16.34M

Enterprise Value

16.38M

Revenue

186.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.37

Market Cap Chart

Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 16.34M, a decrease of -83.98%. That is a compound annual growth rate of -13.45%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	16.34M	114.71%
Dec 31, 2025	7.61M	-74.20%
Dec 31, 2024	29.50M	82.56%
Dec 29, 2023	16.16M	41.33%
Dec 30, 2022	11.43M	-85.60%
Dec 31, 2021	79.42M	-13.96%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
European Medical Solutions	23.02M
BioSenic	1.63M
Hyloris Pharmaceuticals	187.60M
Onward Medical	228.51M
Oxurion NV	392.55K
Financière de Tubize	10.10B
argenx SE	39.31B
UCB SA	50.08B

Market Cap Rankings